Ratio Analysis Report
Public Company Ratios vs. Industry Ratios
GREAT FEATURE: To find the meaning or usage of any term, just click on the ratio analysis term to enter the Glossary.
CREATE YOUR OWN SAMPLE: Enter stock ticker below and click 'Submit'.
This online report is prepared by VentureLine
| TERM |
Qtr. End 03/31/13 |
Qtr. End 03/31/12 |
Year End 12/31/12 |
Year End 12/31/11 |
Year End 12/31/10 |
Year End 12/31/09 |
Year End 12/31/08 |
| |
GSK |
GSK |
GSK |
2834 |
GSK |
2834 |
GSK |
2834 |
GSK |
2834 |
GSK |
2834 |
| Net Sales in $M |
4,168.4 |
4,277.2 |
17,025.9 |
2,646.1 |
17,641.7 |
2,733.1 |
18,289.1 |
2,598.7 |
18,273.6 |
2,306.4 |
15,686.7 |
2,113.9 |
| |
|
|
|
|
|
|
|
|
|
|
|
|
| PREDICTOR RATIOS: |
Qtr. End 03/31/13 |
Qtr. End 03/31/12 |
Year End 12/31/12 |
Year End 12/31/11 |
Year End 12/31/10 |
Year End 12/31/09 |
Year End 12/31/08 |
| |
GSK |
GSK |
GSK |
2834 |
GSK |
2834 |
GSK |
2834 |
GSK |
2834 |
GSK |
2834 |
| Altman Z-Score |
3.58 |
0.36 |
4.01 |
1.59 |
4.61 |
1.61 |
3.86 |
4.35 |
4.52 |
7.50 |
4.32 |
3.90 |
| Sustainable Growth Rate |
1% |
5% |
16% |
16% |
22% |
17% |
-19% |
15% |
24% |
20% |
21% |
18% |
|
|
| PROFITABILITY RATIOS: |
Qtr. End 03/31/13 |
Qtr. End 03/31/12 |
Year End 12/31/12 |
Year End 12/31/11 |
Year End 12/31/10 |
Year End 12/31/09 |
Year End 12/31/08 |
| |
GSK |
GSK |
GSK |
2834 |
GSK |
2834 |
GSK |
2834 |
GSK |
2834 |
GSK |
2834 |
| P/E Ratio |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
| Gross Profit Margin on Sales |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
| Net Profit Margin (Pre-tax) |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
| Net Profit Margin (After-tax) |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
| Operating Expense to Sales |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
| Operating Profit to Sales |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
| Basic Earning Power |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
| Return on Assets (After-tax) |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
| Return on Equity |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
| |
|
|
|
|
|
|
|
|
|
|
|
|
| ASSET MANAGEMENT RATIOS: |
Qtr. End 03/31/13 |
Qtr. End 03/31/12 |
Year End 12/31/12 |
Year End 12/31/11 |
Year End 12/31/10 |
Year End 12/31/09 |
Year End 12/31/08 |
| |
GSK |
GSK |
GSK |
2834 |
GSK |
2834 |
GSK |
2834 |
GSK |
2834 |
GSK |
2834 |
| Collection Period (Period Average) |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
| Collection Period (Period End) |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
| Inventory Turns (Period Average) |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
| Inventory Turns (Period End) |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
| Days Inventory |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
| Working Capital Turnover |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
| Fixed Asset Turnover |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
| Total Asset Turnover |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
| |
|
|
|
|
|
|
|
|
|
|
|
|
| LIQUIDITY RATIOS: |
Qtr. End 03/31/13 |
Qtr. End 03/31/12 |
Year End 12/31/12 |
Year End 12/31/11 |
Year End 12/31/10 |
Year End 12/31/09 |
Year End 12/31/08 |
| |
GSK |
GSK |
GSK |
2834 |
GSK |
2834 |
GSK |
2834 |
GSK |
2834 |
GSK |
2834 |
| Current Ratio |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
| Quick Ratio |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
| Sales/Receivables |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
| Gearing Ratio |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
| |
|
|
|
|
|
|
|
|
|
|
|
|
| DEBT MANAGEMENT RATIOS: |
Qtr. End 03/31/13 |
Qtr. End 03/31/12 |
Year End 12/31/12 |
Year End 12/31/11 |
Year End 12/31/10 |
Year End 12/31/09 |
Year End 12/31/08 |
| |
GSK |
GSK |
GSK |
2834 |
GSK |
2834 |
GSK |
2834 |
GSK |
2834 |
GSK |
2834 |
| Times Interest Earned |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
| Equity Multiplier |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
| Fixed Assets (net)/Net Worth |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
| Debt Ratio |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
| Debt to Equity |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
| Long-term-debt to Equity |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
| Current-debt to Total Debt |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
Sample |
|
N/A: Data unavailable in order to calculate ratio
Z: Data equals zero in ratio denominator